DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Sharma P, Siefker-Radtke A, de Braud F. , et al.
Nivolumab alone and with ipilimumab in previously treated metastatic urothelial carcinoma: CheckMate 032 nivolumab 1 mg/kg plus ipilimumab 3 mg/kg expansion cohort results.
J Clin Oncol 2019;
37 (19) 1608-1616
We do not assume any responsibility for the contents of the web pages of other providers.